Software development
x
- info@bioicawtech.com
- Helsinki, Finland
- Request a quote
BioICAWtech can provide AI based chemoinformatics analysis for variety of in-silico applications.
We can provide statistical analysis, predictive modelling, database development, scrapping/harmonizing data from public sources, manuscript writing and grant writing for any of these five applications.
BioICAWtech can also develop AI based methods and workflows to facilitate precision medicine application if multi-omics data for patients are provided.
Scientists at BioICAWtech have developed several pipelines for analyzing bulk RNA and single cell sequencing. One of the sample pipelines is shown in the following figure.
Product
Our company main products
Drug repurposing
We have extensive experience in developing in-silico methods for drug repurposing. Our scientists have been the primary authors in four drug-repurposing related survey articles.
RepurposeDrugs catalogue
RepurposeDrugs is a web-portal that combines a unique drug indication database with a machine learning (ML) predictor to discover new drug-indication.
PharmacoProfiler
Hamonizes and provide visual analytics on drug response data. Portal also integrates ML based live prediction of drug responses for uploaded any compounds.
AI based drug-response prediction using multi-omics
Multi-omics data integration has become a potent strategy for improving the precision of drug response prediction models.
Identification of synergistic drug combinations
We have recently started developing computational workflow which can identify potential synergistic drug combinations which are also safe to use.
AI based prediction of adverse drug reactions
The post-marketing reports of adverse events for approved drugs and their combinations are available in VigiBase, FAERS, VAERS and JADER databases.
Working Areas
Application Areas
Research
Publications
DrugRepo: A novel approach to repurpose a huge collection of compounds based on chemical and genomic features
Authors: Yinyin Wang, Jehad Aldahdooh, Hongbin Yang, Jing Tang, Ziaurrehman TanoliUsing BERT to identify drug-target interactions from whole
PubMed
Authors: Jehad Aldahdooh, Markus Vähä-Koskela, Jing Tang, Ziaurrehman Tanoli
Play Video
Recent Article
Interesting Articles
06May
Efficacy vs Potency
by admin, 0 Comments
Potency is the concentration (EC50) or dose (ED50) of a drug required ...
90%
70%
Machine learning
80%
Data analysis
90%
Data engineering
Testimonials
What our clients say?
BiolCAWtech performed excellent services, combining unconventional thinking, timeliness, and very deep scientific expertise. I highly recommend their services.
Danny (Technology Entrepreneur)
USAThe programming services provided by BioICAWTech were superb. Not only did they complete my complex project before my deadline at an affordable price, but the BioICAWTech team was responsive to my questions, helpful, and professional. I will definitely work with them again in the future!
(Assistant Professor, University of Split School of Medicine)
Croatia
